Status In progress
Technology type Medicine
Decision Selected
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
Process STA Standard
ID number 6497

Provisional Schedule

Committee meeting: 1 11 November 2025
Expected publication 28 January 2026

Project Team

Project lead Louise Jafferally

Email enquiries

Stakeholders

Companies sponsors SIFI S.p.a. (polihexanide)
Others Department of Health and Social Care
  NHS England
Patient carer groups Eyecare Trust
  Fight for Sight
  Guide Dogs
  Macular Society
  National Federation of the Blind of the UK
  Royal National Institute of Blind People (RNIB)
  SeeAbility
  Sense
  South Asian Health Foundation
  Specialised Healthcare Alliance
  Thomas Pocklington Trust
Professional groups Association of Optometrists
  British and Irish Orthoptic Society
  British Geriatrics Society
  British Ophthalmic Anaesthesia Society (BOAS)
  College of Optometrists
  Neonatal and Paediatric Pharmacists Group
  Optical Confederation
  Royal College of General Practitioners
  Royal College of Nursing
  Royal College of Ophthalmologists
  Royal College of Paediatrics & Child Health
  Royal College of Pathologists
  Royal College of Physicians
  Royal Pharmaceutical Society
  Royal Society of Medicine
  UK Clinical Pharmacy Association
Associated public health groups Public Health Wales
  UK Health Security Agency
Comparator companies Thorton & Ross Ltd (propamidine)
General commentators All Wales Therapeutics and Toxicology Centre
  Allied Health Professionals Federation
  Board of Community Health Councils in Wales
  British National Formulary
  Care Quality Commission
  Department of Health - Northern Ireland
  Healthcare Improvement Scotland
  Medicines and Healthcare products Regulatory Agency
  National Association of Primary Care
  National Pharmacy Association
  NHS Confederation
  NHS Wales Joint Commissioning Committee
  Scottish Medicines Consortium
  Wales Council for the Blind
  Welsh Government
Relevant research groups Cochrane Eyes and Vision Group
  Eye Hope
  Genomics England
  Institute of Ophthalmology, University College London
  MRC Clinical Trials Unit
  National Eye Research Centre
  National Institute for Health Research
  National Institute for Health Research Biomedical Research Centre for Ophthalmology, Moorfields Eye Hospital and UCL Institute of Ophthalmology

Timeline

Key events during the development of the guidance:

Date Update
11 April 2025 Invitation to participate
22 January 2025 - 19 February 2025 Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: ID6497
22 January 2025 In progress. Scoping commenced.
25 October 2024 Awaiting development. Status change linked to Topic Selection Decision being set to Selected

For further information on our processes and methods, please see our CHTE processes and methods manual